Biopharmaceutical applications of α-galactosidases

被引:5
作者
Anisha, Grace Sathyanesan [1 ]
机构
[1] Govt Coll Women, Postgrad & Res Dept Zool, Thiruvananthapuram, Kerala, India
关键词
blood group conversion; Fabry's disease; flatulence; xenotransplantation; alpha-galactosidase; BROAD SUBSTRATE-SPECIFICITY; ENZYME REPLACEMENT THERAPY; GOOD HYDROLYTIC ACTIVITY; RED-BLOOD-CELLS; GROUP-B; FABRY-DISEASE; N-ACETYLGALACTOSAMINIDASE; PHARMACOLOGICAL CHAPERONE; DOUBLE-BLIND; RESISTANT;
D O I
10.1002/bab.2349
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Galactosidases are exoglycosidases that are active on galactose-containing side chains in oligosaccharides, polysaccharides, glycolipids, and glycoproteins. alpha-Galactosidases are gaining increased interest in human medicine, especially in the enzyme replacement therapy for Fabry's disease. alpha-Galactosidases with regioselectivity toward alpha-1,3-linked galactose find application in xenotransplantation and blood group transformation. The use of alpha-galactosidases as a therapeutic agent in alleviating the postprandial symptoms of irritable bowel syndrome is much acclaimed. The excellent therapeutic applications of alpha-galactosidases have led to an upwelling of worldwide research interventions to identify novel alpha-galactosidases with improved catalytic efficiency. In addition to these therapeutic applications, alpha-galactosidases also have interesting applications in the industrial sectors like food, feed, probiotics, sugar, and paper pulp. The current review focuses on the diverse therapeutic applications of alpha-galactosidases and their prospects.
引用
收藏
页码:257 / 267
页数:11
相关论文
共 74 条
[1]   Optimization of Saccharomyces cerevisiae α-galactosidase production and application in the degradation of raffinose family oligosaccharides [J].
Alvarez-Cao, Maria-Efigenia ;
Cerdan, Maria-Esperanza ;
Gonzalez-Siso, Maria-Isabel ;
Becerra, Manuel .
MICROBIAL CELL FACTORIES, 2019, 18 (01)
[2]   Microbial α-galactosidases: Efficient biocatalysts for bioprocess technology [J].
Anisha, Grace Sathyanesan .
BIORESOURCE TECHNOLOGY, 2022, 344
[3]   Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors [J].
Arends, Maarten ;
Biegstraaten, Marieke ;
Hughes, Derralynn A. ;
Mehta, Atul ;
Elliott, Perry M. ;
Oder, Daniel ;
Watkinson, Oliver T. ;
Vaz, Frederic M. ;
van Kuilenburg, Andre A. B. P. ;
Wanner, Christoph ;
Hollak, Carla E. M. .
PLOS ONE, 2017, 12 (08)
[4]  
Bakunina IY, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1209
[5]   Molecular Characterization and Therapeutic Potential of a Marine Bacterium Pseudoalteromonas sp KMM 701 α-Galactosidase [J].
Balabanova, Larissa A. ;
Bakunina, Irina Yu. ;
Nedashkovskaya, Olga I. ;
Makarenkova, Ilona D. ;
Zaporozhets, Tatiana S. ;
Besednova, Natalia N. ;
Zvyagintseva, Tatiana N. ;
Rasskazov, Valery A. .
MARINE BIOTECHNOLOGY, 2010, 12 (01) :111-120
[6]   Microbial production and biotechnological applications of α-galactosidase [J].
Bhatia, Sonu ;
Singh, Abhinashi ;
Batra, Navneet ;
Singh, Jagtar .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 150 :1294-1313
[7]   Systemic Treatment of Fabry Disease Using a Novel AAV9 Vector Expressing α-Galactosidase A [J].
Biferi, Maria Grazia ;
Cohen-Tannoudji, Mathilde ;
Garcia-Silva, Andrea ;
Souto-Rodriguez, Olga ;
Vieitez-Gonzalez, Irene ;
San-Millan-Tejado, Beatriz ;
Fernandez-Carrera, Andrea ;
Perez-Marquez, Tania ;
Teijeira-Bautista, Susana ;
Barrera, Soraya ;
Dominguez, Vanesa ;
Marais, Thibaut ;
Gonzalez-Fernandez, Africa ;
Barkats, Martine ;
Ortolano, Saida .
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 20 :1-17
[8]   A randomized double-blind placebo-controlled crossover pilot study: Acute effects of the enzyme α-galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients [J].
Bohn, Lena ;
Tornblom, Hans ;
Van Oudenhove, Lukas ;
Simren, Magnus ;
Storsrud, Stine .
NEUROGASTROENTEROLOGY AND MOTILITY, 2021, 33 (07)
[9]  
Chauhan Aishwarya Singh, 2015, Biotechnol Res Int, V2015, P860343, DOI 10.1155/2015/860343
[10]   Bioevaluation of sixteen ADMDP stereoisomers toward alpha-galactosidase A: Development of a new pharmacological chaperone for the treatment of Fabry disease and potential enhancement of enzyme replacement therapy efficiency [J].
Cheng, Wei-Chieh ;
Wang, Jen-Hon ;
Li, Huang-Yi ;
Lu, Sheng-Jhih ;
Hu, Jia-Ming ;
Yun, Wen-Yi ;
Chiu, Cheng-Hsin ;
Yang, Wen-Bin ;
Chien, Yin-Hsiu ;
Hwu, Wuh-Liang .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 123 :14-20